In particular, while most of the previous studies primarily compared the differences by artificially expressing each polymorphic p53 codon 72 vector in the p53 null cancer cell lines, our study comparatively analyzed isogenic lines capable of endogenously expressing either P72 or R72, based on induced pluripotent stem cells generated from normal human fibroblasts. The gene discussed is TP53; the disease is cancer.